Demographic Characteristics of Participants in Rheumatoid Arthritis Randomized Clinical Trials
Authors:
Open Access
- 1 November 2019
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 2 (11) , e1914745
Abstract
Rheumatoid arthritis (RA) is associated with significant morbidity and mortality, resulting in substantial health care utilization and cost. Approximately 1.5 million people in the United States have RA, accounting for 0.6% of the adult population.1 Racial/ethnic minority groups, women, and elderly people experience a disproportionate burden of RA, making it particularly important to examine therapies in these populations.2-9Keywords
This publication has 28 references indexed in Scilit:
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisArthritis Care & Research, 2012
- Racial and ethnic disparities in disease activity and function among persons with rheumatoid arthritis from university‐affiliated clinicsArthritis Care & Research, 2011
- The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseasesArthritis & Rheumatism, 2010
- Understanding why rheumatoid arthritis patient treatment preferences differ by raceArthritis Care & Research, 2009
- Racial Disparities in Treatment Preferences for Rheumatoid ArthritisMedical Care, 2009
- Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA StudyArthritis Research & Therapy, 2009
- The Inclusion of Women and Minorities in Smoking Cessation Clinical Trials: A Systematic ReviewThe American Journal on Addictions, 2009
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IArthritis & Rheumatism, 2007
- Participation Rates in Epidemiologic StudiesAnnals of Epidemiology, 2007
- Pharmacokinetic and Pharmacodynamic Changes in the ElderlyClinical Pharmacokinetics, 1998